Ask Sophie: I work at OpenAI on an H-1B. How can I explore immigration...

Sophie Alcorn Contributor Sophie Alcorn is the founder of Alcorn Immigration Law in Silicon Valley and 2019 Global Law Experts Awards’ “Law Firm of the...

SentinelOne acquires Peak XV-backed PingSafe for over $100 million

SentinelOne’s deal to acquire PingSafe valued the Peak XV-backed young startup at over $100 million, two sources familiar with the matter told TechCrunch,...

Don’t wait until Black Friday, grab a Nintendo Switch 2 and two of its...

If you've been waiting for a decent Nintendo Switch 2 discount before picking up the new console, then I've managed to find the...

23andMe confirms hackers stole ancestry data on 6.9 million users

On Friday, genetic testing company 23andMe announced that hackers accessed the personal data of 0.1% of customers, or about 14,000 individuals. The company...

Canada’s StackAdapt snaps up $235M for its AI-based programmatic platform

While the U.S. and Canada duke it out over tariffs between the two countries, a tech company based out of Toronto is announcing...

Choosing the right deep tech fund manager: 4 essential questions for investors and founders

Champ Suthipongchai Contributor Champ Suthipongchai is a co-founder and general partner at Creative Ventures, a method-driven deep tech VC firm investing in startups that address...

7 most underrated Breaking Bad episodes ever, ranked

Few shows have as many great episodes as Breaking Bad. Over the course of its five seasons, the show produced a number of all-time...

Moving on from SBF trial with Circle IPO rumors, a massive new crypto fund...

Welcome back to Chain Reaction. To get a roundup of TechCrunch’s biggest and most important crypto stories delivered to your inbox every Thursday at...

IndieBio’s SF incubator lineup is making some wild biotech promises

IndieBio’s Bay Area incubator is about to debut its 15th cohort of biotech startups. We took special notice of a few, which were...

New pre-seed funds are popping up everywhere

“There are still healthy gains to be had” Among the doom and gloom felt lately in venture capital investments and returns, there seems to...